4D Molecular Therapeutics

4D Molecular Therapeutics is a clinical-stage biotechnology company focused on developing innovative gene therapies to address serious unmet medical needs. Utilizing its proprietary Therapeutic Vector Evolution platform, the company creates customized adeno-associated virus (AAV) vectors designed to target specific tissues affected by disease. With a diverse pipeline of product candidates, 4DMT aims to revolutionize genetic medicine and provide transformative benefits to patients. ([4dmoleculartherapeutics.com](https://4dmoleculartherapeutics.com/about/?utm_source=openai))